List of works by Sridhar Natesan

Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease

scientific article published on 21 July 2015

Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine

scientific article

Antipsychotic therapy over half a century: a tale of discovery from chlorpromazine to aripiprazole

scientific article published in July 2012

Chronic exposure to haloperidol and olanzapine leads to common and divergent shape changes in the rat hippocampus in the absence of grey-matter volume loss

scientific article published on 12 August 2016

Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation

scientific article published on 15 January 2012

Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment

scientific article

Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation.

scientific article

Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [¹¹C]MP-10 PET rodent imaging study with ex vivo confirmation.

scientific article

Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways.

scientific article published on 15 January 2013

Haloperidol modulates noradrenergic responses to aversive stimulation depending on treatment duration

scientific article

Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers

scientific article published on 15 July 2016

Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease

scientific article published on 25 July 2015

Microglial activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses

scientific article published on 17 August 2015

Modeling chronic olanzapine exposure using osmotic minipumps: pharmacological limitations

scientific article published on 03 August 2011

Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models

scientific article published on 19 November 2010

Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human

article

Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107.

scientific article

Reduced cortical volume and elevated astrocyte density in rats chronically treated with antipsychotic drugs-linking magnetic resonance imaging findings to cellular pathology

scientific article published on 19 October 2013

Reply to: Lithium and the Expanding Brain

Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine

scientific article published on 07 May 2020

Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?

scientific article (publication date: November 2016)

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats

scientific article published on 14 January 2020

The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist

scientific article

The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study

scientific article published on 17 July 2021

Paulina is supported by:

About Paulina

Help